InsidersTradesSigma
HCA Healthcare, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)
Follow the HCA Healthcare, Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, HCA Healthcare, Inc. has published 290 public disclosures. Market capitalisation: €93.9bn. The latest transaction was disclosed on 30 April 2026 (Attribution). Among the most active insiders: Whalen Kathleen M. The full history is free.
290
Insider Decl.
0
Thresholds
€1m
5 ops.
Buy Volume
€84m
68 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate HCA Healthcare, Inc. Buy (bullish), based on 21 analysts. Average price target: US$497.29.
33Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 6,624 of 25,889 companies
63.8
score / 100
Value74
Quality54
FCF yld8.5%
Earn yld7.5%
EV/EBITDA8.9x
ROE·
Gross mgn42%
Net mgn9.0%
Debt/EBITDA3.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 30 April 2026
Declarations290 total
809 shares0Common StockSEC:0001193125-26-197734:0
509 shares0Common StockSEC:0001193125-26-197746:0
1,041 shares0Common Stock, par value $0.01 per shareSEC:0001140361-26-018352:0
809 shares0Common Stock, par value $0.01 per shareSEC:0001140361-26-018355:0
809 shares0Common StockSEC:0001193125-26-197757:0
925 shares0Common StockSEC:0001193125-26-197763:0
509 shares0Common StockSEC:0001193125-26-197773:0
509 shares0Common StockSEC:0001193125-26-197781:0
15,698 shares@ US$369.324869.4% of flowCommon StockSEC:0000950170-25-072914:0
90,076 shares0Common StockSEC:0000950170-25-072916:0
466 shares0Common StockSEC:0000950170-25-067306:0
1,026 shares0Common StockSEC:0000950170-25-062126:0
645 shares0Common StockSEC:0000950170-25-062120:0
645 shares0Common StockSEC:0000950170-25-062141:0
1,320 shares0Common Stock, par value $0.01 per shareSEC:0001140361-25-016961:0
645 shares0Common StockSEC:0000950170-25-062139:0
1,026 shares0Common Stock, par value $0.01 per shareSEC:0001140361-25-016965:0
1,026 shares0Common StockSEC:0000950170-25-062112:0
1,173 shares0Common StockSEC:0000950170-25-062136:0
670 sharesCommon StockSEC:0001140361-25-010977:0
Ideal exit: 21 Apr 2012 (T+270)
13,218 shares0Common StockSEC:0000950170-25-022662:0
845 shares0Common StockSEC:0000950170-25-022666:0
1,588 shares0Common StockSEC:0000950170-25-022648:0
845 shares0Common StockSEC:0000950170-25-022667:0
2,330 shares0Common StockSEC:0000950170-25-022652:0
25 of 290 declarations
About HCA Healthcare, Inc.
HCA Healthcare, Inc. (ticker HCA) is one of the largest for-profit healthcare services groups listed in the United States, and it trades on the NYSE (United States). Headquartered in Nashville, Tennessee, the company was founded in 1968 by Dr. Thomas Frist Sr., Dr. Thomas Frist Jr., and Jack C. Massey. Its original mission was to create a new model for hospital care built on scale, operational discipline, and clinical quality. That founding ethos still shapes HCA Healthcare’s strategy today, making it a long-established benchmark in the U.S. hospital and acute-care market. ([hcahealthcare.com](https://hcahealthcare.com/about/our-history.dot?utm_source=openai)) HCA Healthcare operates an extensive healthcare network that includes hospitals, ambulatory surgery centers, freestanding emergency rooms, urgent care centers, physician clinics, and other outpatient care sites. Its footprint is concentrated primarily in the United States, with an additional presence in the United Kingdom. The company describes itself as a learning health system, using a very large volume of patient encounters to support clinical improvement, research, and operational efficiency. ([investor.hcahealthcare.com](https://investor.hcahealthcare.com/news/news-details/2026/HCA-Healthcare-Named-a-Worlds-Most-Admired-Company-by-Fortune-for-the-12th-Consecutive-Year/default.aspx?utm_source=openai)) From a competitive standpoint, HCA’s strengths are its scale, integrated delivery model, broad geographic reach, and ability to expand higher-acuity specialty services alongside outpatient care. The group has also invested in digital and clinical systems intended to improve care coordination and productivity across its network. For investors, this mix matters because it supports a diversified revenue base within a highly fragmented U.S. healthcare landscape, while also giving HCA leverage on purchasing, staffing, and network optimization. ([investor.hcahealthcare.com](https://investor.hcahealthcare.com/news/news-details/2024/HCA-Healthcare-Releases-2024-Annual-Impact-Report/default.aspx?utm_source=openai)) Recent developments underscore the company’s operating momentum and strategic priorities. In first-quarter 2026, HCA reported revenue of $19.109 billion, up 4.3% year over year, net income attributable to HCA of $1.620 billion, and operating cash flow up 22.0%. Management also noted modest growth in admissions and emergency-room visits, while citing seasonal and weather-related pressures on volumes. In 2025, HCA continued to highlight community investment, nursing education support, and healthcare workforce initiatives, reflecting both its social footprint and the labor challenges facing the sector. ([investor.hcahealthcare.com](https://investor.hcahealthcare.com/news/news-details/2026/HCA-Healthcare-Reports-First-Quarter-2026-Results/default.aspx?utm_source=openai))
